Shimadzu Launches Blood-Based Amyloid Mass Spectrometry Service in North America for Supporting Alzheimer’s Disease Drug Discovery and Development
July 08, 2022Shimadzu Scientific Instruments announces the successful commercialization of a new Amyloid Mass Spectrometry (MS) Service...